BioFire Defense

The CDC has issued a Health Alert Network (HAN) Health Advisory regarding a sharp rise in domestically acquired Cyclospora infections across multiple U.S. states.

Cyclospora is notoriously easy to miss using conventional testing methods, and because molecular panel compositions vary widely, it is omitted from many gastrointestinal panels on the market today. True diagnostic readiness means eliminating these blind spots before they impact operational capability. Both the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel and the GI Panel Mid include Cyclospora cayetanensis as a standard target, delivering automated, laboratory-grade precision in about an hour to give clinical and defense networks absolute diagnostic clarity.

Read the full CDC Health Advisory for detailed recommendations on recognition, diagnosis, and reporting: https://www.cdc.gov/han/php/notices/han00531.html
BioFire Defense is the sole supplier of bioMérieux's BIOFIRE® product line to the Department of Defense, the Defense Health Agency, and other federal agencies.

Domestically Acquired Cyclosporiasis Cases in Multiple U.S. States, 2026 Domestically-Acquired Cyclosporiasis Cases in Multiple U.S. States, 2026

In high-stakes environments, there is no substitute for proficiency. BioFire Defense supports the mission of the Department of Defense (DoD) by ensuring users are experts in the BIOFIRE® ecosystem.

Through specialized educational materials and in-depth technical summaries, we help Military Health System teams move from sample to decisive action with confidence. Supporting those who support the force is our primary objective.

BioFire Defense is the sole supplier of the BIOFIRE portfolio of multiplex PCR diagnostic tests to the DoD and other U.S. Government agencies.

Strengthen your diagnostic readiness today: https://biofiredefense.com/contact-us/